SCHEMBL7779894

SCHEMBL7779894

CC#Cn1nc(-c2ccc(S(C)(=O)=O)cc2)c(-c2ccc(Cl)cc2Cl)c1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 17/20 0.43
PTGS1 P23219 4/20 0.40
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7778057 0.91 PTGS1 (0.51) PTGS2PTGS1CYP2C9
SCHEMBL7780616 0.88 PTGS2 (0.53) PTGS2PTGS1
SCHEMBL7778111 0.85 PTGS2 (0.47) PTGS2PTGS1CYP2C9
SCHEMBL7779562 0.82 PTGS2 (0.66) PTGS2PTGS1
SCHEMBL7780819 0.81 PTGS2 (0.45) PTGS2PTGS1CYP2C9
SCHEMBL7780488 0.81 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL7779888 0.81 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL7779756 0.80 PTGS2 (0.43) PTGS2PTGS1CYP2C9
SCHEMBL7773253 0.80 PTGS2 (0.65) PTGS2PTGS1
SCHEMBL7780776 0.80 PTGS2 (0.54) PTGS2PTGS1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed